BioStock: MDR certification was Enzymatica’s highlight in Q1 - Börskollen
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Investeringsmöjlighet: Etablerat bolag som står inför accelererad tillväxt – nu kan du bli delägare (annons)

Pressmeddelande

BioStock: MDR certification was Enzymatica’s highlight in Q1

Cision Publicerad: 29 Apr 10:13
Enzymatica

Enzymatica has recently published its Q1 report, where the MDR certification for ColdZyme stands out as the key milestone during the quarter.
– The MDR certification was a labor-intensive and costly process, but now that ColdZyme has been certified as one of the first cold products in Europe, it opens up great commercial opportunities.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/04/mdr-certification-was-enzymaticas-highlight-in-q1/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Nyheter om Enzymatica

Läses av andra just nu

Om aktien Enzymatica

Senaste nytt